Munich Ardana plc, an emerging pharmaceutical company based in Edinburgh and a portfolio company of DVC Deutsche Venture Capital, has successfully completed its IPO on the London Stock Exchange (LSE) on March 4th. 16,400,000 shares were issued at 128 pence per share raising gross proceeds of £21m. Ardana shares will trade under the ticker symbol ARA.L.
